Xianbin Yang, PhD, MBA Director AM Biotechnologies How did you become interested in the field of oligonucleotides? I’ve been fascinated with nucleic acid chemistry and biology since my undergraduate study. I received my
Eli Gilboa Ph.D. Dodson Professor of Microbiology & Immunology University of Miami Miller School of Medicine How did you become interested in the field of oligonucleotides? A main interest and focus of my lab is cancer immunotherapy. The overall approach has been
Maureen McKeague, PhD, Postdoctoral Scholar, Bioengineering Department, Stanford University How did you become interested in the field? I’ve been fascinated with nucleic acids ever since high school biology. In my undergraduate degree, I enjoyed genetics
Fritz Eckstein, PhD Max Planck Institute for Experimental Medicine Dr. Eckstein received a Ph.D. in chemistry in 1960 at the University of Bonn in Germany. This was followed by a postdoctoral time at the University of Toronto for 2 years with Prof. H. Baer [...]
ProQR Therapeutics Property, Head of Intellectual Property How did you become interested in the field? I am a Dutch and European patent attorney with a Masters in Chemical Biology/Molecular Biology from Utrecht University, The Netherlands (Msc. 1988).
Jana McCaskill, PhD University of Edinburgh Biography: Jana received her PhD in 2014, working with Nigel McMillan at the University of Queensland Diamantina Institute (Australia). Her doctoral work focused on the development and systemic liposomal delivery of respiratory syncytial virus and Hendra virus targeted siRNAs. [...]
Frank Rigo, PhD Ionis Pharmaceuticals, Inc. Biography: In 2002, Frank completed his undergraduate studies in molecular biology and biochemistry at Marquette University. From 2002-2008, Frank earned his Ph.D. at UCLA in the Biochemistry Department under Harold Martinson. There, he dissected the mechanistic basis for how [...]
How did you become interested in the field? I was working in 1981 as an organic chemist at NIH in the former FDA Bureau of Biologics (now Center for Drug Evaluation & Research), and was asked to help clone the gene for human C-reactive protein by making the required hybridization probe—a mixed-sequence 11-mer oligodeoxynucleotide,
Takenori Shimo received both his B.S. and M.Sc. in Pharmaceutical Sciences from Osaka University, Japan. He is currently a doctoral candidate in the Graduate School of Pharmaceutical Sciences, Osaka University. His research interests include nucleic acid chemistry, especially modulating splicing by using antisense oligonucleotides.
Dale Guenther University of Idaho Biography: Dale Guenther is a graduate student at the University of Idaho working under the supervision of Dr. Patrick Hrdlicka. Her graduate research centers on the development of energetically activated duplexes, termed Invader probes, for mixed-sequence recognition of dsDNA. These [...]